# Workspace Changelog

Chronological lab notebook for this workspace: what changed, what failed, what was verified, and what should happen next.

## 2026-07-02 — leJEPA soundness research (`jepa-vs-traditional-cv-ml`)

**Objective**: check whether the leJEPA-based approach in `docs/superpowers/specs/2026-07-02-lejepa-tissue-classifier-design.md` is a sound choice for the NCT-CRC-HE-100K tissue classifier, versus traditional CV/ML and existing pathology foundation models. Framed as portfolio-project research supporting a job application (Aganitha, Computer Vision Engineer — Biomedical Imaging).

**Process**: Feynman `/deepresearch`-style workflow, adapted to Claude Code tooling. Plan → independent fable-subagent plan review (flagged model-tiering and one-sidedness issues, fixed before execution) → 6 parallel researcher subagents (haiku for search-heavy tasks, sonnet for theory/judgment-heavy tasks) → lead-synthesized draft → verifier subagent (sonnet, citation checks via arXiv/GitHub APIs) → adversarial reviewer subagent (opus) → fix pass → delivered.

**Verified**: `PASS WITH NOTES`. Delivered brief at `outputs/jepa-vs-traditional-cv-ml.md`, provenance at `outputs/jepa-vs-traditional-cv-ml.provenance.md`.

**Key finding**: NCT-CRC-HE-100K/CRC-VAL-HE-7K is already near-saturated by supervised/transfer learning (94.3-98.3% published), and SSL's classical label-efficiency advantage doesn't apply to a fully-labeled dataset. Existing open pathology foundation models (Virchow, GigaPath, UNI) offer a faster, more job-relevant path than pretraining leJEPA from scratch, though their specific accuracy figures on this dataset are reported, not independently confirmed (two behind paywalls). leJEPA's own counter-argument (in-domain SSL beating transfer on visually-specialized domains, per its Galaxy10 result) is real but untested on histology — treated as a live open question, not refuted.

**Verification caught a real issue**: a citation-verification pass found one claim (leJEPA underperforming MAE/DINOv3 on histopathology, sourced to a University of Kentucky project page) was not actually supported by its cited source when re-fetched directly — likely a fabrication/misread by a haiku-tier researcher subagent. Removed from the final brief rather than merely hedged. A subsequent adversarial review pass also caught the synthesized draft overstating verification status ("already verified" for numbers the brief's own notes called unconfirmed) and an overreaching verdict; both fixed and confirmed on disk before delivery.

**Next recommended step**: revisit `docs/superpowers/specs/2026-07-02-lejepa-tissue-classifier-design.md` in light of this research — decide whether to (a) pivot the project spec to fine-tuning an open pathology foundation model instead of leJEPA pretraining, given it's cheaper and more directly matches the target job description, or (b) keep leJEPA but reframe the project's stated goal explicitly as "demonstrating SSL engineering competence" rather than "maximizing classification accuracy," since the research does not support the latter framing on this specific dataset.
